Doximity Inc
NYSE:DOCS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Wanderport Corp
OTC:WDRP
|
US |
Doximity Inc
Narrow
Economic Moat
Doximity Inc has a narrow economic moat driven by network effects and intangible assets such as strong brand recognition. These factors provide some level of protection against competition but are not insurmountable, allowing for potential challenges over time.
Doximity Inc
Competitive Advantages
Doximity benefits from network effects as its platform becomes more valuable to its users — physicians and healthcare professionals — as more of them join and engage with it. This increases the attractiveness of the platform for new users and creates a barrier to entry for competitors.
Doximity's brand recognition and reputation among healthcare professionals provide intangible assets that help maintain its competitive position in the healthcare networking market.
Wide Economic Moat Companies
| Company | Last Price | Price Change | Market Cap | Economic Moat | ||
|---|---|---|---|---|---|---|
|
|
|
NVIDIA Corp
NVDA
|
$175.75 |
+0.8%
|
$4.3T | Wide |
|
|
|
Apple Inc
AAPL
|
$255.63 |
+2.1%
|
$3.8T | Wide |
|
|
|
Alphabet Inc
GOOGL
|
$297.39 |
-0.2%
|
$3.6T | Wide |
|
|
|
Microsoft Corp
MSFT
|
$369.37 |
+1%
|
$2.7T | Wide |
|
|
|
Amazon.com Inc
AMZN
|
$210.57 |
+1.6%
|
$2.3T | Wide |
|
|
|
Taiwan Semiconductor Manufacturing Co Ltd
2330
|
NT$1 815 |
+2.4%
|
$1.5T | Wide |
|
|
|
Meta Platforms Inc
META
|
$579.23 |
+0.1%
|
$1.5T | Wide |
|
|
|
Broadcom Inc
AVGO
|
$313.49 |
-1.8%
|
$1.5T | Wide |
|
|
|
Walmart Inc
WMT
|
$124.74 |
+0.6%
|
$994.2B | Wide |
|
|
|
Eli Lilly and Co
LLY
|
$954.52 |
-1.3%
|
$902.4B | Wide |
| Company | Last Price | Price Change | Market Cap | Economic Moat | ||
|---|---|---|---|---|---|---|
|
|
|
Hanmi Semiconductor Co Ltd
042700
|
₩273 500 |
+1.5%
|
$18.1B | Wide |
|
|
|
Neurocrine Biosciences Inc
NBIX
|
$132.56 |
+2%
|
$13.2B | Wide |
Doximity Inc
Glance View
Doximity Inc., often regarded as the social network for doctors, has carved a unique niche for itself by seamlessly blending the culture of community with professional networking specifically tailored for the medical field. Founded in 2010 by Jeff Tangney, a co-founder of Epocrates, Doximity leverages technology to connect healthcare professionals nationwide, offering tools for both communication and collaboration. Much like LinkedIn, but with a focus on physicians and clinicians, Doximity provides a platform where medical practitioners can securely connect with colleagues, stay informed about the latest developments in their fields, and peruse professional opportunities. Its services cater not just to social networking, but also to telemedicine, reflecting the modern demands of a rapidly digitizing healthcare landscape. The company monetizes primarily through three main revenue streams: pharmaceutical marketing, hiring solutions, and telehealth services. Pharmaceutical companies pay Doximity for targeted marketing opportunities, allowing them to reach specific segments of the medical community with precision and impact. Additionally, hospitals and medical groups subscribe to its hiring solutions to recruit top-tier medical talent. In an era where telemedicine has become increasingly vital, Doximity’s telehealth solutions have gained traction, enabling physicians to engage in virtual consultations efficiently. This multi-faceted business model allows Doximity to stay at the forefront of digital healthcare services, driving growth while serving a highly specialized market.
Our research into Economic Moat performance spans the past 10 years and focuses on companies with a wide economic moat. For this analysis, we calculated the average stock price returns of these companies, comparing them to the performance of the S&P 500 index over the same period.
The results were compelling: wide moat stocks achieved a remarkable +645% average return, compared to +188% for the broader market. This difference highlights the long-term benefits of investing in businesses that can maintain their market position and pricing power over time.
Note: This research does not account for survivorship bias. Past performance is not indicative of future results.
Economic Moat